Literature DB >> 33394237

Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques.

Oluwayimika E Akinsiku1, Opeyemi S Soremekun1, Mahmoud E S Soliman2.   

Abstract

CBP [cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB)-binding protein] is one of the most researched proteins for its therapeutic function. Several studies have identified its vast functions and interactions with other transcription factors to initiate cellular signals of survival. In cancer and other diseases such as Alzheimer's, Rubinstein-taybi syndrome, and inflammatory diseases, CBP has been implicated and hence an attractive target in drug design and development. In this review, we explore the various computational techniques that have been used in CBP research, furthermore we identified computational gaps that could be explored to facilitate the development of highly therapeutic CBP inhibitors.

Entities:  

Keywords:  Bromodomains; CREB; CREB inhibitors; Molecular dynamic simulation

Mesh:

Substances:

Year:  2021        PMID: 33394237      PMCID: PMC7868315          DOI: 10.1007/s10930-020-09951-8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  64 in total

Review 1.  How well can simulation predict protein folding kinetics and thermodynamics?

Authors:  Christopher D Snow; Eric J Sorin; Young Min Rhee; Vijay S Pande
Journal:  Annu Rev Biophys Biomol Struct       Date:  2005

2.  Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A.

Authors:  S Ait-Si-Ali; S Ramirez; F X Barre; F Dkhissi; L Magnaghi-Jaulin; J A Girault; P Robin; M Knibiehler; L L Pritchard; B Ducommun; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

3.  The bromodomain revisited.

Authors:  F Jeanmougin; J M Wurtz; B Le Douarin; P Chambon; R Losson
Journal:  Trends Biochem Sci       Date:  1997-05       Impact factor: 13.807

4.  Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.

Authors:  J R Lundblad; R P Kwok; M E Laurance; M L Harter; R H Goodman
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

5.  brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2.

Authors:  J W Tamkun; R Deuring; M P Scott; M Kissinger; A M Pattatucci; T C Kaufman; J A Kennison
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

6.  Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism.

Authors:  D Parker; K Ferreri; T Nakajima; V J LaMorte; R Evans; S C Koerber; C Hoeger; M R Montminy
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

7.  Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors.

Authors:  P Brindle; S Linke; M Montminy
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

8.  Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.

Authors:  Ling-Jiao Zou; Qiu-Ping Xiang; Xiao-Qian Xue; Cheng Zhang; Chen-Chang Li; Chao Wang; Qiu Li; Rui Wang; Shuang Wu; Yu-Lai Zhou; Yan Zhang; Yong Xu
Journal:  Acta Pharmacol Sin       Date:  2019-05-16       Impact factor: 6.150

Review 9.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

10.  Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.

Authors:  Ryan A Henry; Yin-Ming Kuo; Andrew J Andrews
Journal:  Biochemistry       Date:  2013-08-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.